Announced
Completed
Financials
Sources
Tags
United Kingdom
biotechnology company
Biotechnology
Single Bidder
Friendly
Private
Minority
Venture Capital
Completed
Acquisition
Private Equity
Cross Border
Synopsis
Foresite Capital, an American venture capital and growth equity firm, and F-Prime Capital, a global venture capital firm investing in healthcare and technology, led a £35m Series C funding round in Genomics, a pioneering health tech company focusing on polygenic risk scoring, with participation from Infinity Investment Partners and MassMutual. “Our vision is that in 10 to 15 years’ time, genetic information will be ubiquitous in healthcare systems,” Peter Donnelly, Genomics CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.